Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author does not hold a position in SNPS.
← Back to Free Index

SNPS

Analysis as of: 2026-04-07
Synopsys, Inc.
Synopsys sells chip design, verification, semiconductor interface IP, hardware-assisted validation, and engineering simulation software used to build semiconductors and complex products.
ai cloud enterprise semiconductors software
Jump to: SummaryAnalysisOpportunityRiskTrendsLE StructureThird Party Analyst Consensus

Summary

Broader engineering control with a cleaner rerating path
The core case is a reset-quality compounder: Synopsys already sits in hard-to-replace design workflows, and the merger widens its reach into system simulation. The upside depends on proving cross-sell and IP recovery, not on speculative AI hype.

Analysis

Thesis
Synopsys should outperform as AI makes chip and system engineering more complex, because it already controls trusted design, verification, and simulation workflows; the Ansys deal expands that control point, while debt paydown and better IP execution can turn today’s reset valuation into a solid 5-year double.
Last Economy Alignment
AI makes chips and system design harder, not easier, so more budget flows to trusted design, verification, and simulation workflows where Synopsys is deeply embedded.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
1.9x (from 5 most recent analyses)
Reasoning
This looks like a high-quality compounder rather than a moonshot. The upside comes from low-teens revenue growth, modest share gains across a broader engineering stack, and balance-sheet repair. If Synopsys proves the merger creates real cross-sell and restores Design IP execution, the stock can re-rate from a reset base without needing an extreme terminal multiple.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The main risks are execution, not product relevance. Synopsys now has to prove the Ansys combination creates durable wallet-share gains, restore Design IP delivery, and navigate China exposure while carrying a larger debt load. If those issues drag on, the company can remain strategically important yet trade more like a mature engineering software vendor than a premium AI-era compounder.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Last Economy Structure

AI Industrial Score
0.85
They sit in the trusted software path engineers use to design, test, and approve chips and complex products, so cheaper AI labor tends to increase demand for their workflows. The main threat is not replacement by chatbots, but big customers insourcing pieces and China rules interrupting demand.
Upgrade to Reader to also access: Score Decomposition, Confidence Level
Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility
Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target
$537.75
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case